Hyperamylasemia and S-type Isozyme Dominance in Liver Cirrhosis

Overview

Journal Int J Pancreatol

Specialty Gastroenterology

Date 1987 Oct 1

PMID 2447210

Authors

Y Hatta

N Yoshikawa

H Funatomi

S Taguchi

Affiliations

Soon will be listed here.

Abstract

To investigate the mechanisms of serum amylase abnormalities in liver disease, we determined serum amylase levels, S-type isozyme proportion, clinical symptoms, and laboratory data in 38 cases of histologically confirmed liver cirrhosis and 19 controls. Of the 12 patients who were hyperamylasemic (12/38, 32%), 5 showed S-type isozyme dominance (5/12, 42%), whereas in the 26 normoamylasemic cirrhosis patients, only 5 were S-type isozyme dominant (5/26, 19%). Isozyme percentages were significantly higher (P less than 0.01) in the dominant-S-type cases than in the controls, and S-type dominance was found more frequently in the hyperamylasemic than in the normoamylasemic cirrhosis cases. Only ascites and esophageal varices were observed more frequently as clinical symptoms in the dominant-S-type cases. Our results suggest that amylase is not produced in the human liver, but that the decreased clearance rate of amylase, especially the S-type isozyme, may be a cause of hyperamylasemia and S-type isozyme dominance in cirrhosis.

References

Janowitz H, DREILING D . The plasma amylase. Source, regulation and diagnostic significance. Am J Med. 1959; 27:924-35. DOI: 10.1016/0002-9343(59)90176-7. View

Kumar S, Gupta M, Tyagi S . A study of serum amylase in infective hepatitis. J Indian Med Assoc. 1970; 55(6):194-7. View

Joseph R, Olivero E, RESSLER N . Electrophoretic study of human isoamylases. A new saccharogenic staining method and preliminary results. Gastroenterology. 1966; 51(3):377-82. View

Benjamin D, Kenny M . Clinical value of amylase isoenzyme determinations. Am J Clin Pathol. 1974; 62(6):752-8. DOI: 10.1093/ajcp/62.6.752. View

Mordoh J, KRISMAN C, Parodi A, LELOIR L . Some properties of rat liver amylase. Arch Biochem Biophys. 1968; 127(1):193-9. DOI: 10.1016/0003-9861(68)90216-6. View

Vinicor F, Lehrner L, Karn R, MERRITT A . Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med. 1979; 91(2):200-4. DOI: 10.7326/0003-4819-91-2-200. View

Rutter W, Arnold M, BROSEMER R, Miller J . Liver amylase. II. Physiological role. J Biol Chem. 1961; 236:1259-63. View

FRIDHANDLER L, BERK J, Ueda M . Isolation and measurement of pancreatic amylase in human serum and urine. Clin Chem. 1972; 18(12):1493-7. View

Rajasingham R, Bell J, Baron D . A comparative study of the isoenzymes of mammalian alpha-amylase. Enzyme. 1971; 12(2):180-6. DOI: 10.1159/000459530. View

10.

Bhutta I, Rahman M . Serum amylase activity in liver disease. Clin Chem. 1971; 17(12):1147-9. View

11.

Warshaw A, Feller E, Lee K . On the cause of raised serum-amylase in diabetic ketoacidosis. Lancet. 1977; 1(8018):929-31. DOI: 10.1016/s0140-6736(77)92225-5. View

12.

Gunaga K, SHETH A, Rao S . Localization of maltase and amylase in the human prostate. Indian J Med Res. 1968; 56(2):208-10. View

13.

McGEACHIN R, Potter B, Lindsey A . PUROMYCIN INHIBITION OF AMYLASE SYNTHESIS IN THE PERFUSED RAT LIVER. Arch Biochem Biophys. 1964; 104:314-7. DOI: 10.1016/s0003-9861(64)80019-9. View

14.

De la Lande F, Boettcher B . Electrophoretic examination of human serum amylase isoenzymes. Enzymologia. 1969; 37(5):335-42. View

15.

Warshaw A, Lee K . Characteristic alterations of serum isoenzymes of amylase in diseases of liver, pancreas, salivary gland, lung, and genitalia. J Surg Res. 1977; 22(4):362-9. DOI: 10.1016/0022-4804(77)90158-5. View

16.

Morrissey R, BERK J, FRIDHANDLER L, Pelot D . The nature and significance of hyperamylasemia follwing operation. Ann Surg. 1974; 180(1):67-71. PMC: 1343609. DOI: 10.1097/00000658-197407000-00009. View

17.

Wands J, Salyer D, Boitnott J, Maddrey W . Fulminant hepatitis complicated by pancreatitis. Johns Hopkins Med J. 1973; 133(3):156-60. View

18.

Knight A, Williams D, Ellis G, Goldberg D . Significance of hyperamylasaemia and abdominal pain in diabetic ketoacidosis. Br Med J. 1973; 3(5872):128-31. PMC: 1586360. DOI: 10.1136/bmj.3.5872.128. View

19.

Belfiore F, Napoli E . Interpretation of hyperamylasemia in diabetic coma. Clin Chem. 1973; 19(4):387-9. View

20.

BERK J, Hayashi S, Searcy R, HIGHTOWER Jr N . Differentiation of parotid and pancreatic amylase in human serum. Am J Dig Dis. 1966; 11(9):695-701. DOI: 10.1007/BF02239422. View